Waddell & Associates »

BioMarin Pharmaceutical shares owned by Waddell & Associates

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Waddell & Associates from 13F filings

Historical chart of Waddell & Associates investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Waddell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Waddell & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $529k 9.4k 56.49
2025-12-31 $290k 4.9k 59.43
2025-09-30 $280k 5.2k 54.16
2025-06-30 $318k 5.8k 54.97

More positions owned by Waddell & Associates

FedEx Corporation (FDX)
Global X Fds Us Infr Dev Etf (PAVE)
Pacer Fds Tr Globl Cash Etf (GCOW)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Schwab Strategic Tr Fundamental Us S (FNDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Global X Fds Adaptive Us (AUSF)
Schwab Strategic Tr 1000 Index Etf (SCHK)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Direxion Shares Etf Trust Nasdaq 100 Eq Wt (QQQE)
Abrdn Fds Emerging Mkts Di (AGEM)
Apple (AAPL)
NVIDIA Corporation (NVDA)

View all positions for Waddell & Associates

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Viking Global Investors
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Capital Research Global Investors
Millennium Management

View all funds holding BioMarin Pharmaceutical